Literature DB >> 29574042

Modeling the performance of carrier-based dry powder inhalation formulations: Where are we, and how to get there?

Mustafa M A Elsayed1, Ahmed O Shalash2.   

Abstract

Development of carrier-based dry powder inhalation formulations follows till date empirical approaches. This is mainly underlain by numerousness of interplaying determinants of performance and complexity of involved interactions. Mathematical modeling helps elucidate such interactions and aids rational development of formulations. This article provides a critical overview of attempts made to model the performance of carrier-based dry powder inhalation formulations. The complex dependence of the performance on formulation properties is comprehensively discussed. A potential microstructure-based model is ultimately introduced.
Copyright © 2018 Elsevier B.V. All rights reserved.

Keywords:  Dry powder inhalation; Excipient/carrier; Mathematical modeling; Microstructure; Physicochemical determinants of performance

Mesh:

Substances:

Year:  2018        PMID: 29574042     DOI: 10.1016/j.jconrel.2018.03.020

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  3 in total

1.  Inhalable Nanocomposite Microparticles with Enhanced Dissolution and Superior Aerosol Performance.

Authors:  Chune Zhu; Jianting Chen; Shihui Yu; Chailu Que; Lynne S Taylor; Wen Tan; Chuanbin Wu; Qi Tony Zhou
Journal:  Mol Pharm       Date:  2020-07-24       Impact factor: 4.939

Review 2.  Nanocrystals based pulmonary inhalation delivery system: advance and challenge.

Authors:  Pengfei Yue; Weicheng Zhou; Guiting Huang; Fangfang Lei; Yingchong Chen; Zhilin Ma; Liru Chen; Ming Yang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

3.  To Enhance Mucus Penetration and Lung Absorption of Drug by Inhalable Nanocrystals-In-Microparticles.

Authors:  Guiting Huang; Shuyuan Shuai; Weicheng Zhou; Yingchong Chen; Baode Shen; Pengfei Yue
Journal:  Pharmaceutics       Date:  2022-02-28       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.